# Targeting the TGFβ pathway for cancer therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeting-the-tgf-pathway-for-cancer-therapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Cindy Neuzillet,Annemilaï Tijeras‐Raballand,Romain Cohen,Jérôme Cros,Sandrine Faivre,Éric Raymond,Armand de Gramont |
| Citations | 620 |
| DOI | 10.1016/j.pharmthera.2014.11.001 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.pharmthera.2014.11.001 |
| OpenAlex ID | https://openalex.org/W2000315116 |
| PMID | 25444759 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Jérôme Cros](https://scholariq.org/researchers/jerome-cros/)

## Paper journal

- [Pharmacology & Therapeutics](https://scholariq.org/journals/pharmacology-and-therapeutics/)

## Paper primary topic

- [TGF-β signaling in diseases](https://scholariq.org/topics/tgf-signaling-in-diseases/)

## Paper topics

- [TGF-β signaling in diseases](https://scholariq.org/topics/tgf-signaling-in-diseases/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.